Why use of dienogest for the first contraceptive pill with estradiol?

References

• Lippert TH, Mueck AO. The clinical importance of dienogest. In: Teichmann AT, editor. Dienogest – preclinic and clinic of a new progestogen. 2nd ed. Berlin, New York: Walter de Gruyter Verlag; 1995. pp 261–274.
   Google Scholar
• Oettel M, Elger W, Gräser T, Holz C, Lähteenmäki P, Patchev V. What is past is prologue: estrogen/progestin replacement tomorrow. Gynecol Endocrinol 2001;15(Suppl 4):68–90.
   PubMedGoogle Scholar
• Guengerich FP. Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs. Am J Obstet Gynecol 1990;163:2159–2163.
   PubMed Web of Science ®Google Scholar
• Kuhl H. Pharmacokinetics of oestrogens and progestogens. Maturitas 1990;12:171–197.
   PubMed Web of Science ®Google Scholar
• Köhler G, Faustmann TA, Gerlinger C, Seitz C, Mueck AO. A dose-ranging study to determine the efficacy and safety of dienogest 1, 2, and 4 mg daily in the treatment of endometriosis. Int J Gynecol Obstet, in press.
   Google Scholar
• Fruzetti F. Use of natural estradiol in contraception. Contraception, in press.
   Google Scholar
• von Schoultz B. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment. Climacteric 2003;6(Suppl 2):24–32.
   PubMedGoogle Scholar
• Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitude of German Women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 2004;69:37–42.
   PubMed Web of Science ®Google Scholar
• Zimmerman H, Thebault JJ, Duvauchelle T, Mignot A, Renoux A, Gualano V. Pharmacokinetics of estradiol valerate 2mg + dienogest 2 mg after single and repeated oral administration in healthy postmenopausal women. Clin Drug Invest 2000;20:123–134.
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H. Biochemical markers surrogating on vascular effects of sex steroid hormones. Gynecol Endocrinol 2006;22:163–173.
   PubMed Web of Science ®Google Scholar
• Mueck AO, Seeger H, Lippert TH. Effect of dienogest on the calcium-influx in human cell cultures. In: Teichmann AT, editor. Dienogest – preclinic and clinic of a new progestogen. 2nd ed. Berlin, New York: Walter de Gruyter Verlag; 1995. pp 135–139.
   Google Scholar
• Mueck AO, Seeger H, Lüdtke R, Gräser T, Wallwiener D. Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest. Maturitas 2001;38:305–313.
   PubMed Web of Science ®Google Scholar
• Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Shizuka M, Imada K, Kato S, Mizuguchi K. Dienogest is a selective progesterone agonist in transactivation analysis with potent endometrial activity due to its efficient pharmacokinetic profile. Steroids 2008;73:222–231.
   PubMed Web of Science ®Google Scholar
• Saletu B. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest. Climacteric 2003;6(Suppl 2):37–45.
   PubMedGoogle Scholar
• Linzmayer L, Semlitsch HV, Saletu B, Böck G, Saletu-Zyhlarz G, Zoghlami A, Gruber D, Metka M, Huber J, Oettel M, et al Double-blind, placebo-controlled psychometric studies on the effect of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Drug Res 2001;51:238–245.
   PubMed Web of Science ®Google Scholar
• Oettel M, Gräser T, Hoffman H. Why dienogest as a progestogenic component of postmenopausal nonandrogenic hormone replacement therapy. Drugs Today 2001;37(Suppl G):3–15.
   Google Scholar
• Schneider HP. The role of antiandrogens in hormone replacement therapy. Climacteric 2000;3(Suppl 2):21–27.
   PubMedGoogle Scholar
• Köhler G, Göretzlehner G, Amon I. Therapy of endometriosis with dienogest. Zentralbl Gynäkol 1987;109:795–801.
   PubMedGoogle Scholar
• Cosson M, Querleu D, Donnez J, Madelenat P, Konincks P, Audebert A, Manhes H. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertil Steril 2002;77:684–692.
   PubMed Web of Science ®Google Scholar
• Schindler AE, Christensen B, Henkel A, Oettel M, Moore C. High-dose pilot study with the novel progestogen dienogest in patients with endometriosis. Gynecol Endocrinol 2006;22:9–17.
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H, Terakawa N. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009;91:675–681.
   PubMed Web of Science ®Google Scholar
• Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril 2005;83:1530–1535.
   PubMed Web of Science ®Google Scholar
• Fu L, Osuga Y, Morimoto C, Hirata T, Hirota Y, Yano T, Taketani Y. Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. Fertil Steril 2008;89:1344–1347.
   PubMed Web of Science ®Google Scholar
• Moore C, Feichtinger W, Klinger G. Clinical findings with the dienogest-containing oral contraceptive Valette®. Drugs Today 1999;35:53–68.
   Web of Science ®Google Scholar
• Zimmermann T, Dietrich H, Wisser KH, Hoffmann H. The efficacy and tolerability of Valette®: a postmarketing surveillance study. Eur J Contracept Reprod Health Care 1999;4:155–164.
   PubMed Web of Science ®Google Scholar
• Römer T, Göretzlehner G. Kontrazeption mit OC in 111 Problemfällen, Berlin: Walter de Gruyter; 2008.
   Google Scholar
• Nahum GG, Parke S, Wildt L, Efficacy and tolerability of a new oral contraceptive containing estradiol and dienogest. Obstet Gynecol 2008;111:S15.
   PubMed Web of Science ®Google Scholar
• Parke S, Makalova D, Ahrendt H-J, Mansour D. Bleeding patterns and cycle control with a novel four-phasic combined oral contraceptive containing estradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2008;13:94–95.
   Google Scholar